FIGURE 5.
Astrocyte loss in vivo resulted in local disruption of myelin integrity. (A) Experimental design. (B,C) Compared to control segments (B,B’), CID treated segments of GFAP-iCP9 animals had a reduction in GFAP+ cells (C) and reduction in MBP expression (C’). (D,E) Representative toluidine blue stained images of 1μm spinal cord sections from adult GFAP-iCP9 mice after intrathecal injection of CID. Local astrocyte loss resulted in loss of myelin (D) and myelin decompaction (E). (F,G) Ultrastructural analysis confirms loss of myelin integrity while axons remain morphologically relatively normal (G). Scale Bars: (D) 20 μm; (E) 5 μm; (F) 5 μm; (G) 1 μm; (B,C) 200 μm.